RBPMS2 can inhibit the NLRP3 / caspase-1 / GSDMD signaling pathway to resist pyroptosis in gastric cancer cells

Abstract Gastric cancer (GC) is one of the most common malignancies worldwide, and its development is closely associated with the abnormal expression of numerous genes. RNA - binding protein with multiple splicing 2 (RBPMS2), a member of the RNA - binding protein family, has recently been found to b...

Full description

Saved in:
Bibliographic Details
Main Authors: Nailin Zhang, Lina Yan, Hua Cao, Nana Zhang, Tong Zhang, Shengjiang Guan, Qiquan Liu
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-01125-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849238873872269312
author Nailin Zhang
Lina Yan
Hua Cao
Nana Zhang
Tong Zhang
Shengjiang Guan
Qiquan Liu
author_facet Nailin Zhang
Lina Yan
Hua Cao
Nana Zhang
Tong Zhang
Shengjiang Guan
Qiquan Liu
author_sort Nailin Zhang
collection DOAJ
description Abstract Gastric cancer (GC) is one of the most common malignancies worldwide, and its development is closely associated with the abnormal expression of numerous genes. RNA - binding protein with multiple splicing 2 (RBPMS2), a member of the RNA - binding protein family, has recently been found to be abnormally activated in GC cells. Meanwhile, pyroptosis, a form of programmed cell death, is related to tumorigenesis, development, and immune responses.This study investigated the role of the RNA - binding protein RBPMS2 in GC. It revealed the high expression of RBPMS2 in GC cells and its association with poor prognosis. RBPMS2 promoted the proliferation, invasion, and migration of GC cells while inhibiting pyroptosis by suppressing the NLR family pyrin domain containing 3 (NLRP3)/caspase − 1/gasdermin (DGSDMD) signaling pathway. Knocking out RBPMS2 activated pyroptosis, leading to cell membrane damage and increased expression of pyroptosis - related proteins. The NLRP3 inhibitor MCC950 reversed these effects, confirming the involvement of this pathway. These findings suggest that RBPMS2 may be a potential therapeutic target for inducing pyroptosis in gastric cancer cells, providing novel insights into treatment strategies for gastric cancer.
format Article
id doaj-art-c43b1d46fb7b4784959ee70ca5f896e2
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-c43b1d46fb7b4784959ee70ca5f896e22025-08-20T04:01:23ZengNature PortfolioScientific Reports2045-23222025-07-0115111310.1038/s41598-025-01125-9RBPMS2 can inhibit the NLRP3 / caspase-1 / GSDMD signaling pathway to resist pyroptosis in gastric cancer cellsNailin Zhang0Lina Yan1Hua Cao2Nana Zhang3Tong Zhang4Shengjiang Guan5Qiquan Liu6Department of Spleen and Stomach Diseases, Hebei Provincial Hospital of Chinese MedicineSchool of Public Health, Hebei Medicine UniversityGraduate school, Hebei University of Chinese MedicineRespiratory department, The Fourth Hospital of Hebei Medical UniversityRespiratory department, The Fourth Hospital of Hebei Medical UniversityPharmaceutical Department, Hebei Provincial Hospital of Chinese MedicineDepartment of Spleen and Stomach Diseases, Hebei Provincial Hospital of Chinese MedicineAbstract Gastric cancer (GC) is one of the most common malignancies worldwide, and its development is closely associated with the abnormal expression of numerous genes. RNA - binding protein with multiple splicing 2 (RBPMS2), a member of the RNA - binding protein family, has recently been found to be abnormally activated in GC cells. Meanwhile, pyroptosis, a form of programmed cell death, is related to tumorigenesis, development, and immune responses.This study investigated the role of the RNA - binding protein RBPMS2 in GC. It revealed the high expression of RBPMS2 in GC cells and its association with poor prognosis. RBPMS2 promoted the proliferation, invasion, and migration of GC cells while inhibiting pyroptosis by suppressing the NLR family pyrin domain containing 3 (NLRP3)/caspase − 1/gasdermin (DGSDMD) signaling pathway. Knocking out RBPMS2 activated pyroptosis, leading to cell membrane damage and increased expression of pyroptosis - related proteins. The NLRP3 inhibitor MCC950 reversed these effects, confirming the involvement of this pathway. These findings suggest that RBPMS2 may be a potential therapeutic target for inducing pyroptosis in gastric cancer cells, providing novel insights into treatment strategies for gastric cancer.https://doi.org/10.1038/s41598-025-01125-9RBPMS2Gastric cancerPyrodeathFerroptosisCell multiplicationCell migration
spellingShingle Nailin Zhang
Lina Yan
Hua Cao
Nana Zhang
Tong Zhang
Shengjiang Guan
Qiquan Liu
RBPMS2 can inhibit the NLRP3 / caspase-1 / GSDMD signaling pathway to resist pyroptosis in gastric cancer cells
Scientific Reports
RBPMS2
Gastric cancer
Pyrodeath
Ferroptosis
Cell multiplication
Cell migration
title RBPMS2 can inhibit the NLRP3 / caspase-1 / GSDMD signaling pathway to resist pyroptosis in gastric cancer cells
title_full RBPMS2 can inhibit the NLRP3 / caspase-1 / GSDMD signaling pathway to resist pyroptosis in gastric cancer cells
title_fullStr RBPMS2 can inhibit the NLRP3 / caspase-1 / GSDMD signaling pathway to resist pyroptosis in gastric cancer cells
title_full_unstemmed RBPMS2 can inhibit the NLRP3 / caspase-1 / GSDMD signaling pathway to resist pyroptosis in gastric cancer cells
title_short RBPMS2 can inhibit the NLRP3 / caspase-1 / GSDMD signaling pathway to resist pyroptosis in gastric cancer cells
title_sort rbpms2 can inhibit the nlrp3 caspase 1 gsdmd signaling pathway to resist pyroptosis in gastric cancer cells
topic RBPMS2
Gastric cancer
Pyrodeath
Ferroptosis
Cell multiplication
Cell migration
url https://doi.org/10.1038/s41598-025-01125-9
work_keys_str_mv AT nailinzhang rbpms2caninhibitthenlrp3caspase1gsdmdsignalingpathwaytoresistpyroptosisingastriccancercells
AT linayan rbpms2caninhibitthenlrp3caspase1gsdmdsignalingpathwaytoresistpyroptosisingastriccancercells
AT huacao rbpms2caninhibitthenlrp3caspase1gsdmdsignalingpathwaytoresistpyroptosisingastriccancercells
AT nanazhang rbpms2caninhibitthenlrp3caspase1gsdmdsignalingpathwaytoresistpyroptosisingastriccancercells
AT tongzhang rbpms2caninhibitthenlrp3caspase1gsdmdsignalingpathwaytoresistpyroptosisingastriccancercells
AT shengjiangguan rbpms2caninhibitthenlrp3caspase1gsdmdsignalingpathwaytoresistpyroptosisingastriccancercells
AT qiquanliu rbpms2caninhibitthenlrp3caspase1gsdmdsignalingpathwaytoresistpyroptosisingastriccancercells